Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The EFFEKTOR Study
NCT06059664Phase 2Recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone, sponsored by University of North Carolina at Chapel Hill. Started Apr 2024; status: recruiting.
02
Drugs
finerenone
Beyond the preview
Go deeper on NCT06059664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06059664.